HealthDay - MONDAY, Feb. 15 (HealthDay News) -- Harvard researchers report what
they say is a major advance toward the long-sought goal of a genetic test
that can authoritative between militant prostate cancers that require
urgent therapy and slow-growing tumors that can safely be left
alone.

More: - The rest...